Part 7: The era of reperfusion - Section 2: Acute stroke

Resuscitation

Volumn 46, Issue 1-3, 2000, Pages 239-252

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIAZEPAM; FIBRINOLYTIC AGENT; FOSPHENYTOIN SODIUM; HEPARIN; LABETALOL; LORAZEPAM; LOW MOLECULAR WEIGHT HEPARIN; NIFEDIPINE; NITROPRUSSIDE SODIUM; PHENOBARBITAL; PHENYTOIN; PROUROKINASE; STREPTOKINASE; THIOPENTAL; THROMBIN INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; EMERGENCY TREATMENT; HUMAN; HYPERTENSION; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; SEIZURE; STROKE; TREATMENT INDICATION;

EID: 0034705958     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(00)00282-3     Document Type: Note

References (92)

1. Broderick J.P., Brott T., Tomsick T., Huster G., Miller R. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med. 326:1992;733-736.
2. Stegmayr B., Vinogradova T., Malyutina S., Peltonen M., Nikitin Y., Asplund K. Widening gap of stroke between east and west: eight-year trends in occurrence and risk factors in Russia and Sweden. Stroke. 31:2000;2-8.
3. Thorvaldsen P., Davidsen M., Bronnum-Hansen H., Schroll M. Stable stroke occurrence despite incidence reduction in an aging population: stroke trends in the Danish monitoring trends and determinants in cardiovascular disease (MONICA) population. Stroke. 30:1999;2529-2534.
4. Thorvaldsen P., Kuulasmaa K., Rajakangas A.M., Rastenyte D., Sarti C., Wilhelmsen L. Stroke trends in the WHO MONICA project. Stroke. 28:1997;500-506.
5. Williams G.R., Jiang J.G., Matchar D.B., Samsa G.P. Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke. 30:1999;2523-2528.
6. Grotta J.C. The importance of time. Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. 1997;5-9 National Institute of Neurological Disorders and Stroke, Bethesda, Md.
7. Pepe P.E. Overview: the initial links in the chain of recovery for brain attack: access, prehospital care, notification, and treatment. Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. 1997;17-28 National Institute of Neurological Disorders and Stroke, Bethesda, Md.
8. Spilker J.A. Overview: the importance of patient and public education in acute ischemic stroke. Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. 1997;119-126 National Institute of Neurological Disorders and Stroke, Bethesda, Md.
9. Sayre M.R., Swor R.A., Honeycutt L.K. Prehospital identification and treatment. Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. 1997;35-44 National Institute of Neurological Disorders and Stroke, Bethesda, Md.
10. Kothari R., Sauerbeck L., Jauch E., Broderick J., Brott T., Khoury J., Liu T. Patients' awareness of stroke signs, symptoms, and risk factors. Stroke. 28:1997;1871-1875.
11. Barsan W.G., Brott T.G., Broderick J.P., Haley E.C., Levy D.E., Marler J.R. Time of hospital presentation in patients with acute stroke. Arch Intern Med. 153:1993;2558-2561.
12. Alberts M.J., Perry A., Dawson D.V., Bertels C. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke. 23:1992;352-356.
13. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. Stroke. 28:1997;1530-1540.
14. Crocco T.J., Kothari R.U., Sayre M.R., Liu T. A nationwide prehospital stroke survey. Prehosp Emerg Care. 3:1999;201-206.
15. Ferro J.M., Melo T.P., Oliveira V., Crespo M., Canhao P., Pinto A.N. An analysis of the admission delay of acute strokes. Cerebrovasc Dis. 4:1994;72-75.
16. Kothari R., Jauch E., Broderick J., Brott T., Sauerbeck L., Khoury J., Liu T. Acute stroke: delays to presentation and emergency department evaluation. Ann Emerg Med. 33:1999;3-8.
17. Morris D.L., Rosamond W.D., Hinn A.R., Gorton R.A. Time delays in accessing stroke care in the emergency department. Acad Emerg Med. 6:1999;218-223.
18. Kidwell C.S., Saver J.L., Schubert G.B., Eckstein M., Starkman S. Design and retrospective analysis of the Los Angeles Prehospital Stroke Screen (LAPSS). Prehosp Emerg Care. 2:1998;267-273.
19. Kothari R., Barsan W., Brott T., Broderick J., Ashbrock S. Frequency and accuracy of prehospital diagnosis of acute stroke. Stroke. 26:1995;937-941.
20. Zachariah B., Dunford J., Van Cott C.C. Dispatch life support and the acute stroke patient: making the right call. Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. 1997;29-34 National Institute of Neurological Disorders and Stroke, Bethesda, Md.
21. Davalos A., Castillo J., Martinez-Vila E. Delay in neurological attention and stroke outcome. Stroke. 26:1995;2233-2237.
22. Lyden P.D., Rapp K., Babcock T., Rothcock J. Ultra-rapid identification, triage, and enrollment of stroke patients into clinical trials. J Stroke Cerebrovasc Dis. 4:1994;106-107.
23. Bornstein N.M., Gur A.Y., Fainshtein P., Korczyn A.D. Stroke during sleep: epidemiological and clinical features. Cerebrovasc Dis. 9:1999;320-322.
24. Hazinski M.F. Demystifying recognition and management of stroke. Curr Emerg Card Care. 7:1996;8-9.
25. Broderick J., Brott T., Barsan W. Blood pressure during the first minutes of focal cerebral ischemia. Ann Emerg Med. 22:1993;1438-1443.
26. Maggioni A.P., Franzosi M.G., Farina M.L., Santoro E., Celani M.G., Ricci S., Tognoni G. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. BMJ. 302:1991;1428-1431.
27. Mooe T., Eriksson P., Stegmayr B. Ischemic stroke after acute myocardial infarction: a population based study. Stroke. 28:1997;762-767.
28. Silver F.L., Norris J.W., Lewis A.L. Early mortality following stroke: a prospective review. Stroke. 45:1984;492-496.
29. Tokgozoglu S.L., Batur M.K., Topcuoglu M.A. Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke. 30:1999;1307-1311.
30. Korpelainen J.T., Sotaniemi K.A., Makikallio A. Dynamic behavior of heart rate in ischemic stroke. Stroke. 30:1999;1008-1013.
31. Kothari R.U., Pancioli A., Liu T., Brott T., Broderick J. Cincinnati Prehospital Stroke Scale: reproducibility and validity [see comments]. Ann Emerg Med. 33:1999;373-378.
32. Kidwell C.S., Starkman S., Eckstein M., Weems K., Saver J.L. Identifying stroke in the field: prospective validation of the Los Angeles Prehospital Stroke Screen (LAPSS). Stroke. 31:2000;71-76.
33. Teasdale G., Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet. 2:1974;81-84.
34. Brott G., Adams H.P. Jr, Olinger C.P., et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 20:1989;864-870.
35. Lyden P., Lu M., Jackson C., Marler J., Kothari R., Brott T., Zivin J. NINDS tPA Stroke Trial Investigators. Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. Stroke. 30:1999;2347-2354.
36. Lewandowski C.A., Frankel M., Tomsick T.A., Broderick J., Frey J., Clark W., Starkman S., Grotta J., Spilker J., Khoury J., Brott T. and the Emergency Management of Stroke (EMS) Bridging Trial Investigators. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke. Stroke. 30:1999;2598-2609.
37. DeGraba T.J., Hallenbeck J.M., Pettirew K.D. Progression in acute stroke: value of the initial NIH Stroke Scale score on patient stratification in future trials. Stroke. 30:1999;1208-1212.
38. Davalos A., Toni D., Iweins F., Lesaffre E., Bastianello S., Castillo J. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I. Stroke. 30:1999;2631-2636.
39. Hacke W., Kaste M., Fieschi C., Toni D., Lesaffre E., von Kummer R., Boysen G., Bluhmki E., Hoxter G., Mahagne M.H., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 274:1995;1017-1025.
40. Hunt W.E., Hess R.M. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 28:1968;14-20.
41. Gilman S. Imaging the brain. N Engl J Med. 338:(812-820):1998;889-896.
42. Davis K.R., Ackerman R.H., Kistler J.P. Computed tomography of cerebral infarction: hemorrhagic, contrast enhancement, and time of appearance. Comput Tomogr. 1:1977;71-86.
43. Sames T.A., Storrow A.B., Finkelstein J.A., Magoon M.R. Sensitivity of new-generation computer tomography in subarachnoid hemorrhage. Acad Emerg Med. 3:1996;16-20.
44. Adams H.P. Jr, Kassell N.F., Torner J.C., Sahs A.L. CT and clinical correlations in recent aneurysmal subarachnoid hemorrhage: a preliminary report of the Cooperative Aneurysm Study. Neurology. 33:1983;981-988.
45. Linfante I., Llinas R.H., Caplan L.R. MRI features of intracerebral hemorrhage within 2 hours from symptom onset. Stroke. 30:1999;2263-2267.
46. Schellinger P.D., Jansen O., Fiebach J.B. A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke. 30:1999;765-768.
47. Baird A.E., Benfield A., Schlaug G. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol. 41:1997;581-589.
48. Tong D.C., Yenari M.A., Albers G.W. Correlation of perfusion and diffusion weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology. 50:1998;864-870.
49. Hazinski M.F., Cummins R.O., Field J.M. Handbook of Emergency Cardiovascular Care for Healthcare Providers. Dallas, Tex: American Heart Association; 2000;2000.
50. Barsan W.G. Overview: emergency department management of stroke. Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. 1997;49-54 National Institute of Neurological Disorders and Stroke, Bethesda, Md.
51. Weir C.J., Murray G.D., Dyker A.G. Is hyperglycemia an independent predictor of poor outcome after acute stroke? results of a long-term follow-up study. BMJ. 314:1997;1303-1306.
52. Helgasun C.M. Blood glucose and stroke. Stroke. 19:1988;1049-1053.
53. De Courten-Myers G.M., Kleinholz M., Hulm P., et al. Hemorrhagic infarct conversion in experimental stroke. Ann Emerg Med. 21:1992;210-215.
54. Broderick J.P., Hagen T., Brott T. Hyperglycemia and hemorrhagic transformation of cerebral infarcts. Stroke. 26:1995;4848-4887.
55. Yip P.K., He Y.Y., Hsu C.Y., et al. Effect of plasma glucose on infarct size in focal cerebral ischemia reperfusion. Neurology. 41:1991;899-905.
56. Chew W., Kucharczky J., Moseley M. Hyperglycemia augments ischemic brain injury: in vivo MR imaging spectroscopic study with nicardipine in cats with occluded middle cerebral arteries. Am J Neuroradiol. 12:1991;603-609.
57. Vazquez-Cruz J., Marti-Vilata J.T., Ferrer L. Progressing cerebral infarction in relation to plasma glucose in gerbils. Stroke. 21:1990;1621-1642.
58. Ronning O.M., Guldvog B. Should stroke victims routinely receive supplemental oxygen? a quasi-randomized controlled trial. Stroke. 30:1999;2033-2037.
59. Adams H.J., Brott T., Crowell R., Furlan A., Gomez C., Grotta J., Helgason C., Marler J., Woolson R., Zivin J., Feinberg W., Mayberg M. Guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council. American Heart Association. Stroke. 25:1994;1901-1914.
60. Brott T., Lu M., Kothari R., Fagan S.C., Frankel M., Grotta J.C., Broderick J., Kwiatkowski T., Lewandowski C., Haley E.C., Marler J.R., Tilley B.C. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke. 29:1998;1504-1509.
61. Adams H.J., Brott T., Furlan A., Gomez C., Grotta J., Helgason C., Kiatkowski T., Lyden P., Marler J., Torner J., Feinberg W., Mayberg M., Thies W. Guidelines for Thrombolytic Therapy for Acute Stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. Circulation. 94:1996;1167-1174.
62. Broderick J.P., Adams H.P., Barsan W., Feinberg W., Feldmann E., Grotta J., Kase C., Krieger D., Mayberg M., Tilley B., Zabramski J.M., Zuccarello M. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council. American Heart Association. Stroke. 30:1999;905-915.
63. Qizilbash N., Lewington S.L., Lopez-Arrieta J.M. Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev. 2:2000;CD000064.
64. Tissue plasminogen activator for acute ischemic stroke. [see comments]. N Engl J Med. 333:1995;1581-1587.
65. Clark W., Wissman S., Albers G.W., Jhamanda J.H., Madden K.P., Hamilton S. for the ATLANTIS Stroke Study Investigators. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ALANTIS study: a randomized controlled trial. JAMA. 282:1999;2019-2026.
66. Andreotti F., Pasceri V., Hackett D.R., Davies G.J., Haider A.W., Maseri A. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med. 334:1996;7-12.
67. Thrombolytic and antithrombolytic therapy in acute ischemic stroke: Multicenter Acute Stroke Trial-Italy (MAST-I). del Zoppo G.J., Mori E., Hacke W. Thrombolytic Therapy in Acute Ischemic Stroke. 1993;86-94 Springer-Verlag, New York, NY.
68. Hacke W., Kaste M., Fieschi C., von Kummer R., Davalos A., Meier D., Larrue V., Bluhmki E., Davis S., Donnan G., Schneider D., Diez-Tejedor E., Trouillas P. Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [see comments]. Lancet. 352:1998;1245-1251.
69. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet. 346:1995;1509-1514.
70. Shahar E., McGovern P.G. Trials of streptokinase in severe acute ischaemic stroke [letter]. Lancet. 345:1995;578.
71. del Zoppo G.J., Higashida R.T., Furlan A.J., Pessin M.S., Rowley H.A., Gent M. Prolyse in Acute Cerebral Thromboembolism (PROACT) Investigators. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke [see comments]. Stroke. 29:1998;4-11.
72. Furlan A., Higashida R., Wechsler L., Gent M., Rowley H., Kase C.P.M., Ahuja A., Callahan F., Clark W.M., Silver F., Rivera F. for the PROACT investigators. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II Study: a randomized controlled trial. JAMA. 282:1999;2003-2011.
73. Wardlaw J.M., del Zoppo G., Yamaguchi T. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2:2000;CD000213.
74. Clark W.M., Albers G.W., Madden K.P., Hamilton S. thrombolytic therapy in acute ischemic stroke study investigators. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Stroke. 31:2000;811-816.
75. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 2:1988;349-360.
76. Gilles Geraud A.B. Is anticoagulant therapy too frequently used in ischemic stroke? Cerebrovasc Dis. 1:(suppl 1):1991;120-123.
77. Marsh E.E. III, Adams H.P. Jr, Biller J. Use of antithrombotic drugs in the treatment of acute ischemic stroke: a survey of neurologists in practice in the United States. Neurology. 39:1989;1631-1634.
78. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ. 296:1988;320-331.
79. A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med. 325:1991;1261-1266.
80. Barnett H.J. Aspirin in stroke prevention: an overview. Stroke. 21:(suppl IV):1990;. IV-40 - IV-43.
81. Hass W.K., Easton J.D., Adams H.P. Jr. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med. 321:1989;501-507.
82. The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet. 349:1997;1569-1581.
83. CAST: randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 349:1997;1641-1649.
84. Gubitz G., Sandercock P., Counsell C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2:2000;CD000029.
85. Gubitz G., Counsell C., Sandercock P., Signorini D. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2:2000;CD000024.
86. Clark W.M., Williams B.J., Sacco K.A., Zweifler R.M., Sabounjian L.A., Gamman R.E. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke. 31:1999;2592-2597.
87. Mayberg M.R., Batjer H.H., Dacey R., Diringer M., Haley E.C., Heros R.C., Sternau L.L., Torner J., Adams H.P. Jr, Feinberg W., et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council. American Heart Association. Stroke. 25:1994;2315-2328.
88. Allen G.S., Ahn H.S., Preziosi T.J., Battye R., Boone S.C., Boone S.C., Chou S.N., Kelly D.L., Weir B.K., Crabbe R.A., Lavik P.J., Rosenbloom S.B., Dorsey F.C., Ingram C.R., Mellits D.E., Bertsch L.A., Boisvert D.P., Hundley M.B., Johnson R.K., Strom J.A., Transou C.R. Cerebral arterial spasm: a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 308:1983;619-624.
89. Neil-Dwyer G., Mee E., Dorrance D., Lowe D. Early intervention with nimodipine in subarachnoid haemorrhage. Eur Heart J. 8:1987;41-47.
90. Peturk K.C., West M., Mohr G., et al. Nimodipine treatment in poor-grade aneurysm patients: results of a multi-center double-blind placebo-controlled trial. J Neursorug. 68:1988;505-517.
91. Philippon J., Grob R., Dagreeou F. Prevention of vasospasm in subarachnoid haemorrhage: a controlled study with nimodipine. Acta Neurochir (Wien). 82:1986;110-114.
92. Pickard J.D., Murray G.D., Illingworth R. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 298:1989;636-642.